Canaccord, Peloton

Canaccord Genuity Group reaffirmed their buy rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...
Analysts at Canaccord Genuity slashed their target price on mining services firm Capital from 130.0p to 60.0p on Tuesday and ...
In a report released today, Hayley Palmer from Canaccord Genuity reiterated a Buy rating on Kooth (KOO – Research Report), with a price target ...
Bird Construction (TSE:BDT – Free Report) had its price target decreased by Canaccord Genuity Group from C$36.00 to C$35.00 in a report released on Friday,BayStreet.CA reports. Canaccord Genuity Group ...
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to ...
Fintel reports that on March 14, 2025, Canaccord Genuity upgraded their outlook for Peloton Interactive (LSE:0A46) from Hold to Buy. There are 652 funds or institutions reporting positions in ...
Canaccord Genuity Group began coverage on shares of Planet Fitness (NYSE:PLNT – Free Report) in a research report released on ...
Canaccord Genuity raised its price target on Snowflake (NYSE:SNOW) by $30 to $220, as company is set to report fourth-quarter earnings on Wednesday. Stabilizing growth and AI-driven expansion are key ...